Archer Materials (ASX:AXE) Secures US Patent for Biochip Technology
Archer Materials (ASX:AXE) has secured a key US patent for its Biochip technology, enhancing its prospects in the medical diagnostics market.
Category: Healthcare
LTR Pharma Limited (ASX:LTP) Secures National Distribution Agreement
LTR Pharma Limited (ASX:LTP) partners with Symbion for nationwide distribution of SPONTAN®, enhancing access and operational capabilities.
Emyria Limited (ASX:EMD) Announces Leadership Changes
Emyria Limited (ASX:EMD) announces leadership changes to bolster its growth in mental health treatments.
Evolution Mining Limited (ASX:EVN) Reports Strong December Quarter Performance
Evolution Mining (ASX:EVN) reports substantial cash flow growth and a strong operational performance in its December quarter, with significant achievements in safety and exploration.
Invex Therapeutics Limited (ASX:IXC) Reports December Quarter Activities
Invex Therapeutics Limited (ASX:IXC) reported significant advancements in Exenatide research and a solid financial position in its December quarterly activities update.
Compumedics Limited (ASX:CMP) Signs New 5-Year Contract with Philips Australia
Compumedics Limited (ASX:CMP) announces a new five-year contract with Philips Australia, enhancing its leading Somfit sleep testing program.
Vinyl Group Ltd (ASX: VNL) Successfully Completes Retail Entitlements Offer
Vinyl Group Ltd (ASX: VNL) successfully completed its retail entitlement offer, raising $7.65 million to support acquisitions and growth.
Global Health Limited (ASX: GLH) Reports Strong Cash Flow Growth
Global Health Limited (ASX: GLH) reports significant cash flow growth and revenue increases for December 2024 quarter amidst challenging market conditions.
Recce Pharmaceuticals (ASX:RCE) Achieves Phase II Trial Milestone
Recce Pharmaceuticals (ASX:RCE) successfully dosed all patients in its Phase II trial for R327 topical gel, showing promising preliminary results.
Wellnex Life Limited (ASX:WNX) Announces Pain Away Update
Wellnex Life (ASX:WNX) updates on Pain Away acquisition funding and future dual listing plans.